Medical treatment norms for undivided organizations
I. Diagnostic norms
(i) Clinical performance
Patients usually have a variety of unusual symptoms. In the skin, there are red spots, such as plate-formed ones, and radon-based ones, but they are often less typical than systemic red weeds. The mucous disease includes oral ulcer, which can be repeated. Symptoms of joint muscles are common, in the form of joint pain and swelling, which can be drawn to multiple joints, dominated by small joints, but mostly unrelated deformities. Some of the patients have Reno, i.e. the skin of their fingers or toes becomes white, purple, red, with feelings of pain, numbness, etc. in case of cold or emotional emotion. In addition, there may be systemic symptoms such as inactivity and low heat.
(ii) Laboratory inspection
1. Self-antibody testing: Anti-nuclear (ANA) positive but non-specific self-antibodies such as double-chain DNA antibodies, anti-Sm antibodies, etc. Some of the patients can have a type of rheumatizing factor (RF), some antibodies that can be extracted from the antibodies (ENA), such as anti-U1-RNP antibodies.
2. Other examinations: Blood sunk, C-reacting proteins can rise normally or slightly, reflecting inflammation in the body. Blood routines may be white cell reduction, anaemia or small plate reductions, but do not have characteristics.
(iii) The exclusion of other diseases will require the exclusion of other explicit conjunctive tissue diseases, such as systemic erythroacne, rheumatism, dry syndrome, systemic sclerosis, etc. At the same time, other diseases such as infections, tumours and other diseases that cause similar symptoms are to be eliminated. This can be done by means of detailed inquiries into the history of the disease, medical examinations, video examinations (e.g. X-line, CT, MRI, etc.) and special examinations (e.g. pathogen, tumor markers, etc.).
Treatment norms
(i) The principle of treatment depends on the patient ‘ s symptoms, the severity of the condition and the burden of organs. The objective of treatment is to alleviate symptoms, control the development of conditions, prevent organ damage and improve the quality of life of patients.
(ii) Drug treatment
1. Non-paralytic anti-inflammatory drugs (NSAIDs): for patients with mild joint pains, muscle pains, etc., NSAIDs can be used as an option to mitigate symptoms. However, in the process of use, attention is to be paid to adverse effects such as gastrointestinal tracts and cardiovasculars.
2. hydroxychloride: anti-inflammatory, immuno-regulatory. For patients with skin mucous membrane symptoms, joint symptoms, or mild whole-body symptoms. Periodic eye examinations are required during use to monitor membrane pathologies.
3. Sugar cortex hormones: Sugar cortex hormones may be considered for patients with significant organs (e.g. kidneys, lungs, blood systems, etc.) or severe symptoms. Dose and treatment procedures are adapted to the condition, with attention to adverse effects such as osteoporosis, infection, etc.
Immunosuppressants: Immunosuppressants, such as ammonium butterflies, sulfur, etc., may be used jointly in cases of severe medical conditions or poor hormonal treatment. Indicators such as blood protocol, liver and kidney function are closely monitored during use. At the same time, patients are required to follow up regularly in order to adjust their treatment programmes in a timely manner.
